Cardiac Dysfunction in Patients with Fatty Liver Disease
Recruiting · NCT06386094 · Observational (researchers observe without assigning treatment) · Lead sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Cirrhotic cardiomyopathy is seen as a blunted contractile responsiveness to stress, and/or altered diastolic relaxation with electrophysiological abnormalities, in absence of known cardiac disease. Left ventricular diastolic dysfunction (LVDD) is associated with risk of hepatorenal syndrome (HRS) , septic shock. , heart failure in the perioperative period following liver transplantation, and after trans-jugular intrahepatic portosystemic shunt (TIPS) insertion . The echocardiographic E/e' ratio is a predictor of survival in LVDD, with multiple studies, including prospective data from our Centre. The inability of the heart to cope with stress or sepsis induced circulatory failure is a key concept of the increased mortality risk due to LVDD. In view of the metabolic syndrome and diabetes epidemic and an increasing number of patients being diagnosed with non-alcoholic fatty liver disease, there is increased risk of developing cardiac dysfunction due to multiple comorbidities including coronary artery disease, hypertensive heart disease, cirrhotic cardiomyopathy, which are contributors to overall cardiovascular risk of mortality.
Who can take part
Inclusion criteria
- Age range of 18-65 years
- metabolic dysfunction associated steatotic liver disease as diagnosed either by histology or clinical, laboratory, non invasive tests, USG findings and vibration controlled transient elastography (VCTE).
Exclusion criteria
- Age \>65 years
- Chronic renal disease
- Pregnancy and peripartum cardiomyopathy
- Hypertension
- Valvular heart disease
- Sick sinus syndrome/ Pacemaker
- Cardiac rhythm disorder
- Hypothyroidism
- Hyperthyroidism
- Portal vein thrombosis
- Transjugular intrahepatic porto systemic shunt (TIPS) insertion
- Hepatocellular carcinoma
- Anemia Hb \< 8gm/dl in females, and \< 9 gm/dl in males at the time of assessment
Where it is running
1 location listed.
- Dr. Madhumita Premkumar - Chandigarh, Chandigarh, India